What this means
This trial is still enrolling people, so no results are available yet. It will test whether tirzepatide affects hot flashes and measures of biological aging.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 46–60
- Where
- 1 site, including Florida
The science
- Registered title
- The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
- Trial ID
- NCT07218445 ↗
- Phase
- PHASE 4
- Study type
- interventional
- Conditions
- Obesity, Menopause Hot Flashes
- What is tested
- Tirzepatide, Placebo
- Sponsor
- Mayo Clinic
- Ages
- 46 Years to 60 Years
- Dates
- First posted Oct 20, 2025 · updated Oct 6, 2026
Registry summary
The purpose of this study is to determine the effect of tirzepatide on vasomotor symptoms and on measures of biological aging.
Sites (1)
- Mayo Clinic in Florida, Jacksonville, Florida, United States